News

"The DEA is creating a regulatory paradox where science is stifled and illegal activity is tolerated. Thomas Prevoznik, one unelected bureaucrat should not have the power to derail federally authorize ...
Company announcement - No. 11 / 2025 Zealand Pharma Announces Financial Results for the First Three Months of 2025 Significant progress in the clinical pipeline, strengthening of organizational capabi ...
Zhong Li’s extensive history with the FDA offers crucial lessons on how companies in the pharmaceutical and biopharmaceutical sectors should approach inspection preparedness.  As an experienced FDA ...
In a decisive move to strengthen pharmaceutical regulation, the Ethiopian Food and Drug Authority (EFDA) has revised its directive on the inspection of pharmaceutical manufacturers, aligning national ...
New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states from the European Union (EU) must work more closely together, provide ...
FDA inspections are essential to ensuring the safety and quality of products in the food, pharmaceutical, and medical device industries. One of the experienced professionals in this field is John ...
As the NMPA joins the EU and the U.S. in placing sterility assurance and contamination control front and center, ...
Dublin, May 05, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Chemicals - Global ... chemicals with modern drug development needs. Role of Regulatory Compliance and Quality Standards Compliance ...
The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...
The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...
The inspection was a systems & processes audit resulting in the site approval for all studies conducted at QPS India and submitted by sponsors for US regulatory agency approval. This approval ...
Following President Trump's executive order, the Indian pharmaceutical industry anticipates a surge in unannounced ...